tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nicole Germino, 23 are a BUY (88.46%), 3 are a HOLD (11.54%).
Analyst Nicole Germino, currently employed at TRUIST, carries an average stock price target met ratio of 50.93% that have a potential upside of 63.59% achieved within 196 days.
Nicole Germino’s has documented 48 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 14-Aug-2025.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 5/16/2024. The price target of $48 was fulfilled within 12 days with a profit of $22.9 (91.24%) receiving and performance score of 76.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
4 months 29 days ago
(24-Mar-2025)
0/1 (0%)
$-9.98 (-79.97%)
11 months 2 days ago
(20-Sep-2024)
3/3 (100%)
$-28.44 (-48.67%)
621
Buy
$14
$-11.44 (-44.97%)
$14
2 years 9 months 6 days ago
(16-Nov-2022)
4/4 (100%)
$-1.84 (-11.62%)
328
Buy
$11
$-14.44 (-56.76%)
$12
2 years 9 months 29 days ago
(24-Oct-2022)
5/5 (100%)
$-8.2 (-42.71%)
307
Buy
$12
$-1.72 (-12.54%)
$15
3 years 4 months 21 days ago
(01-Apr-2022)
2/2 (100%)
$-12.72 (-51.46%)
502
Which stock is Nicole Germino is most bullish on?
What Year was the first public recommendation made by Nicole Germino?
